Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Net Margin (2016 - 2025)

Historic Net Margin for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to 13.2%.

  • Haemonetics' Net Margin rose 24400.0% to 13.2% in Q4 2025 from the same period last year, while for Dec 2025 it was 13.31%, marking a year-over-year increase of 38400.0%. This contributed to the annual value of 12.32% for FY2025, which is 33400.0% up from last year.
  • Haemonetics' Net Margin amounted to 13.2% in Q4 2025, which was up 24400.0% from 11.82% recorded in Q3 2025.
  • Haemonetics' Net Margin's 5-year high stood at 17.54% during Q1 2025, with a 5-year trough of 4.91% in Q2 2021.
  • Over the past 5 years, Haemonetics' median Net Margin value was 9.72% (recorded in 2023), while the average stood at 8.62%.
  • Per our database at Business Quant, Haemonetics' Net Margin tumbled by -167600bps in 2021 and then soared by 115900bps in 2025.
  • Haemonetics' Net Margin (Quarter) stood at 6.18% in 2021, then skyrocketed by 75bps to 10.78% in 2022, then dropped by -14bps to 9.29% in 2023, then increased by 16bps to 10.76% in 2024, then increased by 23bps to 13.2% in 2025.
  • Its last three reported values are 13.2% in Q4 2025, 11.82% for Q3 2025, and 10.59% during Q2 2025.